NASDAQ: PRTG
Portage Biotech Inc Earnings Dates, Reports, Calls

Portage Biotech earnings were -$67.3M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest PRTG earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$1.4M, down 18.1% from last quarter. For the last reported fiscal year 2024 ending Mar 31, 2024, PRTG reported annual earnings of -$75.4M, with -28% growth.

PRTG earnings history

Current Revenue
$0.0
Current Earnings
-$67.3M
Current Profit Margin
0%

PRTG Return on Equity

Current Company
-674.4%
Current Industry
19.9%
Current Market
35%
PRTG's Return on Equity (-674.4%)... subscribe to Premium to read more.
High Return on Equity Performance

PRTG undefined

Current Company
-415.8%
Current Industry
1.3%
PRTG is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when PRTG announces earnings.

PRTG undefined

Current Company
-4,189.58%
Current Industry
14.3%
PRTG's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

PRTG vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
PRTG-$76.75M-$67.32MN/A-$64.64
HOTH-$8.19M-$8.19MN/A-$1.28
DWTX-$12.43M-$12.86MN/A-$12.52
NXTC-$52.23M-$55.65MN/A-$1.99
GOVX-$24.88M-$24.99MN/A-$4.82

Portage Biotech Earnings Reports & History FAQ

What were Portage Biotech's earnings last quarter?

On PRTG's earnings call on Invalid Date, Portage Biotech (NASDAQ: PRTG) reported Q3 2024 earnings per share (EPS) of -$1.26, up 78.28% year over year. Total PRTG earnings for the quarter were -$1.36 million. In the same quarter last year, Portage Biotech's earnings per share (EPS) was -$5.80.

If you're new to stock investing, here's how to buy Portage Biotech stock.

Is Portage Biotech profitable or losing money?

As of the last Portage Biotech earnings report, Portage Biotech is currently losing money. Portage Biotech's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$67.32 million, a 40.45% decrease year over year.

What was PRTG's earnings growth in the past year?

As of Portage Biotech's earnings date in Invalid Date, Portage Biotech's earnings has grown year over year. PRTG earnings in the past year totalled -$67.32 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.